Arrhythmias Flashcards
Ectopic beats
spontaneous + pt has normal heart
IF troublesome = beta-blocker sometimes effective
Atrial fibrillation ~ acute presentation
In patients presenting acutely but without life-threatening haemodynamic instability, rate or rhythm control given onset of arrhythmia <48 hours; rate control preferred if onset >48 hours or uncertain. If urgent rate control required, beta-blocker IV; rate-limiting CCB (verapamil) (if left ventricular ejection fraction (LVEF) ≥40%) be given. In patients with suspected concomitant acute decompensated HF, CCB AVOID
— If pharmacological cardioversion agreed, flecainide (if no structural or ischaemic heart disease present) or amiodarone hydrochloride used
Cardioversion
Sinus rhythm restored by electrical cardioversion or pharmacological (anti-arrhythmic drug (flecainide / amiodarone).
~ If >48 hours, electrical cardioversion, but delayed until fully anticoagulated for at least 3 weeks. If not possible, left atrial thrombus ruled out & parenteral anticoagulation (heparin) immediately before cardioversion; oral anticoagulation given after cardioversion + continued for at least 4 weeks
~ During period prior to cardioversion, offer rate control.
~ Amiodarone started 4 weeks before & continued for up to 12 months after electrical cardioversion to maintain sinus rhythm
Rate control in AF
Ventricular rate ~ controlled with standard beta-blocker (NOT sotalol hydrochloride), or with rate-limiting CCB (diltiazem hydrochloride [unlicensed indication] / verapamil as monotherapy)
Digoxin in AF
monotherapy ONLY given for initial rate control in patients with non-paroxysmal atrial fibrillation who predominantly sedentary, or in if rate-limiting drugs unsuitable
Ventricular arrhythmias management
IV lidocaine for ventricular tachycardia or ventricular fibrillation & pulseless ventricular tachycardia in cardiac arrest refractory to defibrillation, but no longer anti-arrhythmic drug of first choice.
Drugs for both supraventricular & ventricular arrhythmias = amiodarone, BB, disopyramide, flecainide, procainamide & propafenone
Mexiletine = tx of life-threatening ventricular arrhythmias
Amiodarone
~ tx of arrhythmias, if other drugs ineffective or contraindicated
~ used for paroxysmal supraventricular, nodal & ventricular tachycardias, atrial fibrillation and flutter, & ventricular fibrillation
~ used for tachyarrhythmias associated with Wolff-Parkinson-White syndrome
~ ONLY start under hospital or specialist supervision
~ can be given by IV infusion & PO , + has advantage of causing little or no myocardial depression
~ very long half life
Anti-arrhythmic drugs Class I
Na+ blockers
1~ disopyramide
2~ Lidocaine
3~ Flecainide / Propafenone (contraindicated in asthma / severe COPD / Avoid in structural / ischaemic heart disease)
Anti-arrhythmic drugs Class II
Beta blockers
~ Propranolol
Anti-arrhythmic drugs Class III
K+ channel blockers
~ Amiodarone (4 weeks before & 12 months after electrical cardioversion)
~ Sotalol
~ Dronedarone (hepatoxicity & HF side effects)
Anti-arrhythmic drugs Class IV
Calcium channel blockers
~ Verapamil
~ Diltiazem (unlicensed)
Anti-arrhythmic drugs Class other
~ Adenosine
~ Digoxin (effective in sedentary pt with non-paroxysmal AF or in associative CHF)
What is AF ?
abnormal, disorganised electrical signals fired as atria quiver / fibrillate = rapid/irregular heartbeat
AF symptoms
~ heart palpitations = pounding / fluttering
~ dizziness, SOB, tiredness
2 main complications of AF
Stroke & HF
3 types of AF
- Paroxysmal : stop within 48h w/o tx
- Persistent : lasts >7 days
- Permanent : present all time
Rate control in AF
controls ventricular rate
Rhythm control in AF
cardioversion (restores sinus rhythm)
1. electrical = direct current
2. Pharmacological = anti-arrhythmic
==> cannot give if symptoms >48h; increased stroke risk
==> electrical preferred if >48h
~ wait until fully anti-coagulated for 3 weeks before cardioversion & cont. 4 weeks after
~ if haemodynamically unstable = electrical cardioversion; give parenteral anti-coagulant (heparin) & rule out atrial thrombus before
acute new-onset of AF
~ life-threatening haemodynamic instability = electrical cardioversion
~ W/O life-threatening haemodynamic instability
— <48h = rate/rhythm control (electrical or amiodarone/flecainide
—>48h = rate control (verapamil, beta blocker)
AF maintenance drug tx
1st line = rate control
~~~ Beta blocker ( NOT sotalol), rate-limiting CCb, digoxin
2nd line = rhythm control
~~~ beta-blocker or oral anti-arrhythmic
e.g. Sotalol, Amiodarone, Flecainide, Propafenone, Dronedarone
paroxysmal or symptomatic AF
~ Ventricular or rhythm control
== beta-blocker or anti-arrhythmias
~ Pill in pocket if infrequent episodes - self tx
== Flecainide or Propafenone = restores sinus rhythm if episode occurs
Stroke prevention in AF
give anti-coagulants if stroke risk > risk of bleed (HAS-BLED)
Risk of stroke CHA2DSVAS tool
C = CHF, left ventricular dysfunction
H = HTN
A2 = 75+
D = DM
S2 = stroke/TIA/VTE hx
V = vascular disease
A = 65-74
Sc = sex i.e. female / male
IF 2 or more = anticoagulant
Male = 0
Female = 1
new-onset AF
Parenteral anticoagulants (Heparin)